Early signs may include persistent pain, unexplained weight loss, abnormal lumps, or changes in bowel or bladder habits.
Discover Hightower Clinical’s clinical studies that helped find a potential hope for those battling with malignant tumors.
Malignant tumors are aggressive cell growths that invade nearby tissues and can spread to other parts of the body. Unlike benign tumors, which are non-cancerous and remain confined, malignant tumors present serious health risks and often create complex medical challenges. These tumors can develop in various organs, leading to a wide range of symptoms and significantly affecting patient well-being. Early detection through proactive screening is essential, as prompt treatment improves outcomes and enhances survival rates.
Hightower Clinical conducted malignant tumor clinical trials in Oklahoma City aimed to advance cancer care by focusing on biomarker analysis to guide treatment strategies. Participants underwent screenings to assess eligibility, received detailed study insights, and were supported throughout the process by expert healthcare professionals. The trials were offered at no cost to participants, including free study-related care, with compensation provided for time and travel.
Not Recruiting
1
Early signs may include persistent pain, unexplained weight loss, abnormal lumps, or changes in bowel or bladder habits.
Screening allows for early detection, leading to timely treatment and better chances of successful outcomes.
Clinical trials test new treatments and techniques, pushing the boundaries of cancer care to find more effective therapies.